Tomoki Makino - Concepedia

Author

Tomoki Makino

The University of Osaka ORCID

Also Known As

Makino, T., Makino, Tomoki, T Makino, T. MAKINO, T. Makino, T., Makino, TOMOKI MAKINO, Tomoki MAKINO, Tomoki Makino

445

Publications

6.9K

Citations

H-Index

100

Concepts

All Affiliations

The University of Osaka Kindai University Osaka International Cancer Institute Osaka Prefectural Medical Center Kyushu University

About

Tomoki Makino is an author at The University of Osaka specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	68	2.9K
2	Health Sciences	8	8	307
3	Business	1	1	50
4	Engineering	1	1	12
5	Public Health	1	1	345

Tomoki Makino

139

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma Yuichiro� Doki, Jaffer A. Ajani, Ken Kato, UCL Discovery (University College London)	2022	532
Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1 Yuko Kitagawa, Ryu Ishihara, Hitoshi Ishikawa, Esophagus EpidemiologyPart 1EsophagusHealth PolicyGastrointestinal Oncology	2023	345
Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2 Yuko Kitagawa, Ryu Ishihara, Hitoshi Ishikawa, Esophagus EsophagusEsophageal CancerGastrointestinal OncologyPart 2Medicine	2023	168
Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma Makoto Yamasaki, Tomoki Makino, Toshimitsu Masuzawa, British Journal of Cancer	2011	132
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma Hisashi Hara, Tsuyoshi Takahashi, Satoshi Serada, British Journal of Cancer	2016	130
Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003) Makoto Yamasaki, Takushi Yasuda, Masahiko Yano, Annals of Oncology Preoperative ChemotherapySurgical OncologyEsophageal CancerGastrointestinal OncologyMedicine	2016	122
High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Kotaro Yamashita, Hiroshi Miyata, Tomoki Makino, Annals of Surgical Oncology Tumor BiologyOncologyEsophageal CancerMedicineHigh Expression	2017	105
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors Yoshinori Hayashi, Tomoki Makino, Eiichi Sato, British Journal of Cancer	2023	97
Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus Tomoki Makino, Makoto Yamasaki, Atsushi Takeno, British Journal of Cancer	2009	88
Tumor‐infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer Kei Yamamoto, Tomoki Makino, Eiichi Sato, Cancer Science	2020	87

Page 1